ConductScience.org, home

Paper4870102

Effect of propranolol on elevated arterial blood pressure.

Richardson DW and 4 others. Circulation, 1968. Cited by 84 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effect of propranolol on elevated arterial blood pressure. Papers, record 4870102. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4870102

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of propranolol on elevated arterial blood pressure.
PubMed
Journal
Circulation
PubMed
Year
1968
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
84
iCite
Revised in PubMed
2022-03-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Richardson DWD W
2Freund JJ
3Gear ASA S
4Mauck HP JrH P
5Preston LWL W

Source PubMed

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
HypertensionMajor topic
PropranololMajor topic
Adult
Aged
Bilirubin
Blood Cell Count
Blood Pressure
Blood Urea Nitrogen
Body Weight
Carbon Dioxide
Chlorides
Chlorthalidone
Clinical Trials as Topic
Creatinine
Female
Heart Rate
Hemoglobinometry
Humans
Male
Middle Aged
Placebos
Posture
Potassium
Sodium

Source PubMed

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.

PMIDTitleJournalYearIn PapersSource
30,174,450Medications that cause weight gain and alternatives in Canada: a narrative review.Diabetes Metab Syndr Obes2018https://conductscience.org/library/papers/30174450PubMed
24,585,007Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/24585007PubMed
18,730,252The clinical use of propranolol.Calif Med1970https://conductscience.org/library/papers/18730252PubMed
6,121,573Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.Br J Clin Pharmacol1982https://conductscience.org/library/papers/6121573PubMed
5,761,914Treatment of hypertension with propranolol.Br Med J1969https://conductscience.org/library/papers/5761914PubMed
5,572,397Serum enzymes and propranolol.Br Med J1971https://conductscience.org/library/papers/5572397PubMed
5,086,971Propranolol and polythiazide in treatment of hypertension.Br Heart J1972https://conductscience.org/library/papers/5086971PubMed
4,907,811Controlled trial of propranolol in hypertension.Br Med J1970https://conductscience.org/library/papers/4907811PubMed
4,591,149Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).Eur J Clin Pharmacol1973https://conductscience.org/library/papers/4591149PubMed
4,554,594Propranolol in hypertension. Report on 158 patients treated up to one year.Klin Wochenschr1972https://conductscience.org/library/papers/4554594PubMed
4,394,369Controlled trial of oxprenolol and practolol in hypertension.Br Med J1970https://conductscience.org/library/papers/4394369PubMed
4,152,167Beta-adrenergic receptor blocking drugs in hypertension.Drugs1974https://conductscience.org/library/papers/4152167PubMed
3,560,241Tailoring antihypertensive drug therapy for the black patient.J Natl Med Assoc1987https://conductscience.org/library/papers/3560241PubMed
2,271,400Racial differences in antihypertensive therapy: evidence and implications.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/2271400PubMed
1,980,202The efficacy of beta-adrenoceptor and calcium-entry blockers in hypertensive blacks.Cardiovasc Drugs Ther1990https://conductscience.org/library/papers/1980202PubMed
786,673Hypotensive effect of oxprenolol in mild to moderate hypertension: a multicentre controlled study.Eur J Clin Pharmacol1975https://conductscience.org/library/papers/786673PubMed
37,094beta-Adrenoceptor blocking effects and pharmacokinetics of pindolol. A study in hypertensive Africans.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/37094PubMed
26,370The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.Br J Clin Pharmacol1978https://conductscience.org/library/papers/26370PubMed
10,438Uses of beta-adrenoceptor blocking drugs.J R Coll Physicians Lond1976https://conductscience.org/library/papers/10438PubMed
6,245Haemodynamic effects of beta-adrenorecptor blockers in hypertension.Drugs1976https://conductscience.org/library/papers/6245PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4870102

GET https://conductscience.org/api/papers/v1/4870102/authors